Structure |
Chemical Name |
CAS |
MF |
|
(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester |
1420478-88-1 |
C18H18BrN5O2 |
|
(9H-fluoren-9-yl)methyl (4-(dimethoxymethyl)phenyl)carbamate |
475160-88-4 |
C24H23NO4 |
|
Posaconazole Impurity 18 |
213381-06-7 |
C37H42F2N8O4 |
|
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile |
1187594-13-3 |
C22H31N7O3SSi |
|
Δ3-Flomoxef sodium |
|
|
|
Derivatives intermediate 3 |
1213710-50-9 |
C21H30N2O |
|
Lixivaptan intermediate-V |
168079-19-4 |
C19H16ClN3O |
|
5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide |
31127-80-7 |
C16H20I3N3O7 |
|
(+)-beta-Pinene oxide |
6931-54-0 |
C10H16O |
|
Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate |
64485-82-1 |
C7H9N3O3S |
|
1H-Tetrazole-1-acetic acid |
21732-17-2 |
C3H4N4O2 |
|
Allopregnanolone |
516-54-1 |
C21H34O2 |
|
4-Methylimidazole |
822-36-6 |
C4H6N2 |
|
methyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)pyrimidine-5-carboxylate |
1057682-17-3 |
C15H22N4O4 |
|
tert-butyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
|
△3-Cefuroxime |
|
|
|
Flomoxef Intermediate KDFA |
|
|
|
Polymethylhydrosiloxane |
9004-73-3 |
C5H11OSi* |
|
(1S,3R,4S)-Ethyl 4-AMino-3-((tert-butoxycarbonyl)aMino)cyclohexanecarboxylate Oxalate |
1093351-24-6 |
C16H28N2O8 |
|
[3S-[3alpha(S*),5alpha]]-3-[[5-(2,4-Difluorophenyl)tetrahydro-5-(iodomethyl)-3-furanyl]carbonyl]-4-(phenylmethyl)-2-oxazolidinone |
165115-89-9 |
C22H20F2INO4 |
|
tert-butyl (S)-1-amino-4-fluoro-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
|
(3R,4S,5R)-Oseltamivir |
|
|
|
1,3-Benzodioxole-5-acetic acid, α-acetyl-, methyl ester |
1369021-80-6 |
C12H12O5 |
|
(9H-fluoren-9-yl)methyl (R)-(3-(4-chlorophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
|
(R)-3-Aminopentanoic acid |
131347-76-7 |
C5H11NO2 |
|
tert-butyl 4-bromo-3-(bromomethyl)thiophene-2-carboxylate |
|
|
|
Zanamivir |
139110-70-6 |
C18H26N2O10 |
|
1-Piperazinecarboxylic acid, 4-(1,3-dihydro-1-oxo-5-isobenzofuranyl)-, 1,1-dimethylethyl ester |
1962174-33-9 |
C17H22N2O4 |
|
Prostaglandin E synthase 3 (PTGES3) Antibody |
|
|
|
(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4h)-trione |
110351-94-5 |
C13H13NO5 |
|
13,14-dihydro Prostaglandin F2a |
|
|
|
Boldenone Cypionate |
106505-90-2 |
C27H38O3 |
|
benzyl (2R,5R)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate |
|
|
|
Methanesulfonic anhydride |
370071-69-5 |
C8H6Br4O2 |
|
Olmesartan intermediate |
|
|
|
(1R,3R)-Methyl-1,2,3,4-tetrahydro-2-chloroacetyl-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate |
|
C22H18ClN2O5- |
|
L-Inosine |
21138-24-9 |
C10H12N4O5 |
|
1H-Pyrrolizine-7a(5H)-carboxylicacid,tetrahydro-,methylester(9CI) |
117375-15-2 |
C9H15NO2 |
|
5-iodo-1-(2-fluoro-2-deoxyribofuranosyl)uracil |
55612-21-0 |
C9H10FIN2O5 |
|
5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole |
368890-20-4 |
C15H12ClF2N3O2S |
|
Morpholin-2-yl-methylamine |
116143-27-2 |
C5H12N2O |
|
3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE (3-EXO)- |
76272-36-1 |
C14H20N2 |
|
(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol |
188399-48-6 |
C13H16O2 |
|
7-Fluoroindole |
387-44-0 |
C8H6FN |
|
DMT-2'O-TBDMS-rA(bz) Phosphoramidite |
104992-55-4 |
C53H66N7O8PSi |
|
1-[2-(Dimethylamino)ethyl]-1H-tetrazole-5-thiol |
61607-68-9 |
C5H11N5S |
|
(S)-(2-Aminomethyl)-1-N-Boc-pyrrolidine HCl |
1190890-11-9 |
C10H21ClN2O2 |
|
3',5'-di-o-acetyl-2-deoxy-5-azacytosine |
22432-93-5 |
C12H16N4O6 |
|
(2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-hydroxymethylpyrrolidine |
317356-27-7 |
C10H18FNO3 |
|
(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride |
170098-28-9 |
C24H31NO3.HCl |
|
4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one |
122584-14-9 |
C17H16BrNO4 |
|
TF-BF |
209861-00-7 |
C24H22F2O5 |
|
Cefaclor, Delta-3 IsoMer |
|
|
|
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride |
1260590-51-9 |
C13H20ClN5 |
|
(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL |
913742-54-8 |
C11H21ClN2O4 |
|
Indacaterol interMediate |
435273-75-9 |
C31H34N2O3 |
|
5-Hydroxy-3,4-dihydroquinolin-2(1H)-one |
30389-33-4 |
C9H9NO2 |
|
2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (2E)- |
899809-64-4 |
C9H11NO4 |
|
Aegelin |
456-12-2 |
C18H19NO3 |
|
1,2,4-cyclohexanetricarboxylic anhydride |
53611-01-1 |
C9H10O5 |
|
3,4-Diethyl 2-aMinothiophene-3,4-dicarboxylate |
104680-25-3 |
C10H13NO4S |
|
tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate |
1172623-99-2 |
C16H21F2NO4 |
|
N,N-Diphenyl-1H-imidazole-1-carboxamide |
2875-79-8 |
C16H13N3O |
|
Coumarin |
10172-76-6 |
C27H21NO6 |
|
Pemetrexed intermediate |
|
|
|
(2S,5S)-ethyl 5-methylpyrrolidine-2-carboxylate 2,2,2-
trifluoro acetate salt |
676560-85-3 |
C10H16F3NO4 |
|
,100kg |
180048-73-1 |
C11H14O4S |
|
1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride |
156077-56-4 |
C12H29ClN4O3 |
|
tert-butyl 4-(4-bromothiazol-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate |
1332301-87-7 |
C13H17BrN2O2S |
|
PPAP |
784118-64-5 |
C14H23N |
|
Cefmetazole Impurity 4 |
68576-47-6 |
C15H17N7O4S4 |
|
Otilonium Bromide intermediates |
51444-79-2 |
C22H27NO4 |
|
(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone |
1027552-46-0 |
C21H22FNO3 |
|
4F-MPH |
1354631-33-6 |
C14H18FNO2 |
|
2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate |
1802250-63-0 |
C15H27ClN2O2 |
|
Oseltamivir-13CD3 |
1093851-61-6 |
C16H28N2O4 |
|
tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate |
177423-00-6 |
C19H38N2O4 |
|
tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate |
1403901-49-4 |
C14H19BrN2O2 |
|
2H-1-Benzopyran-2-one, 6-chloro-4-methyl- |
24145-78-6 |
C10H7ClO2 |
|
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid |
864725-62-2 |
C18H12Cl2F3NO3 |
|
-- |
93360-08-8 |
C30H27N2O6P |
|
Tadanafil intermediate (chloroacetyl porphyrin) |
171596-59-1 |
C31H57BN4O6Si |
|
6-BROMO-4-HYDROXYCOUMARIN |
4139-61-1 |
C9H5BrO3 |
|
ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE |
357326-79-5 |
C10H15NO3 |
|
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
|
LOXO-292 |
2222755-14-6 |
C29H31N9O3 |
|
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |
|
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
|
Prednisone Impurity 13 |
91160-89-3 |
C23H29BrO7 |
|
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
|
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
|
1,4-dihydroxy-2naphthoic acid methyl ester |
77060-74-3 |
C12H10O4 |
|
(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate |
1428484-17-6 |
C36H51F5O4S |
|
3H-3-Azadibenzo[g,ij]naphth[2,1,8-cde]azulene |
2408302-78-1 |
C22H13N |
|
tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
|
(3S,4S,5S)-Oseltamivir |
|
|
|
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
|
(9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)- |
2198312-46-6 |
C12H18BrN3O2 |
|
3-(3'-TRIFLUOROMETHYL PHENYL) PROPANOL |
78573-45-2 |
C10H11F3O |